The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erectile Dysfunction Treatment Drugs Market Research Report 2024
Synopsis
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction Treatment Drugs market was valued at US$ 4855 million in 2023 and is anticipated to reach US$ 6277.1 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs.
Report Scope
The Erectile Dysfunction Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Segment by Type
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction Treatment Drugs market was valued at US$ 4855 million in 2023 and is anticipated to reach US$ 6277.1 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs.
Report Scope
The Erectile Dysfunction Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Segment by Type
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Phosphodiesterase Type 5 Inhibitors
1.2.3 Prostaglandin E1
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Treatment Drugs Market Perspective (2019-2030)
2.2 Erectile Dysfunction Treatment Drugs Growth Trends by Region
2.2.1 Global Erectile Dysfunction Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Erectile Dysfunction Treatment Drugs Historic Market Size by Region (2019-2024)
2.2.3 Erectile Dysfunction Treatment Drugs Forecasted Market Size by Region (2025-2030)
2.3 Erectile Dysfunction Treatment Drugs Market Dynamics
2.3.1 Erectile Dysfunction Treatment Drugs Industry Trends
2.3.2 Erectile Dysfunction Treatment Drugs Market Drivers
2.3.3 Erectile Dysfunction Treatment Drugs Market Challenges
2.3.4 Erectile Dysfunction Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue
3.1.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue (2019-2024)
3.1.2 Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Erectile Dysfunction Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Erectile Dysfunction Treatment Drugs Revenue
3.4 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Treatment Drugs Revenue in 2023
3.5 Erectile Dysfunction Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Erectile Dysfunction Treatment Drugs Product Solution and Service
3.7 Date of Enter into Erectile Dysfunction Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Erectile Dysfunction Treatment Drugs Breakdown Data by Type
4.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Type (2019-2024)
4.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2025-2030)
5 Erectile Dysfunction Treatment Drugs Breakdown Data by Application
5.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Application (2019-2024)
5.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Erectile Dysfunction Treatment Drugs Market Size (2019-2030)
6.2 North America Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2019-2024)
6.4 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Erectile Dysfunction Treatment Drugs Market Size (2019-2030)
7.2 Europe Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2019-2024)
7.4 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size (2019-2030)
8.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Erectile Dysfunction Treatment Drugs Market Size (2019-2030)
9.2 Latin America Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2019-2024)
9.4 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size (2019-2030)
10.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.1.5 Pfizer Inc. Recent Development
11.2 Dong-A Pharmaceutical Co. Ltd
11.2.1 Dong-A Pharmaceutical Co. Ltd Company Detail
11.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
11.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Introduction
11.2.4 Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.2.5 Dong-A Pharmaceutical Co. Ltd Recent Development
11.3 Vivus, Inc.
11.3.1 Vivus, Inc. Company Detail
11.3.2 Vivus, Inc. Business Overview
11.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Introduction
11.3.4 Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.3.5 Vivus, Inc. Recent Development
11.4 Meda Pharmaceuticals
11.4.1 Meda Pharmaceuticals Company Detail
11.4.2 Meda Pharmaceuticals Business Overview
11.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Introduction
11.4.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.4.5 Meda Pharmaceuticals Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Introduction
11.5.4 Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.5.5 Bayer AG Recent Development
11.6 Johnson & Johnson Services
11.6.1 Johnson & Johnson Services Company Detail
11.6.2 Johnson & Johnson Services Business Overview
11.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Introduction
11.6.4 Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.6.5 Johnson & Johnson Services Recent Development
11.7 Apricus Biosciences
11.7.1 Apricus Biosciences Company Detail
11.7.2 Apricus Biosciences Business Overview
11.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Introduction
11.7.4 Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.7.5 Apricus Biosciences Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Introduction
11.8.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2019-2024)
11.8.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
